Related Experiment Video
Updated: Jan 31, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Growth hormone therapy in children; research and practice - A review
Paulo Ferrez Collett-Solberg1, Alexander A L Jorge2, Margaret C S Boguszewski3
1Pediatric Endocrinology, Departamento de Medicina Interna, Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brazil.
Insights
Diagnosing and managing idiopathic short stature in children presents challenges. This review discusses recombinant human growth hormone therapy, genetic testing, and optimizing treatment for better growth outcomes.
Area of Science:
- Pediatric Endocrinology
- Genetics
- Growth Disorders
Background:
- Short stature is a common reason for pediatric endocrinology referrals, posing management challenges.
- Idiopathic short stature diagnosis and the role of genetic investigations are areas of ongoing debate.
- Optimizing recombinant human growth hormone (rhGH) therapy requires careful consideration of patient selection and dosing.
Purpose of the Study:
- To review current controversies and complexities in the diagnosis and management of short stature in children.
- To explore the utility of new genetic technologies in evaluating children with inadequate growth.
- To discuss optimal strategies for recombinant human growth hormone (rhGH) therapy, including dosing and managing suboptimal responses.
Main Methods:
- Literature review of current research and clinical guidelines on short stature management.
- Analysis of the role of anthropometrical, biochemical, and genetic data in treatment decisions.
- Discussion of diagnostic criteria and therapeutic approaches for idiopathic short stature.
Main Results:
- The diagnosis of idiopathic short stature is complex, with emerging genetic technologies offering new insights.
- Selection criteria for recombinant human growth hormone (rhGH) therapy and optimal dosing remain subjects of debate.
- Defining and managing suboptimal responses to growth hormone therapy requires further investigation.
Conclusions:
- Effective management of short stature necessitates a multidisciplinary approach, integrating clinical, genetic, and biochemical data.
- Further research is needed to refine diagnostic tools and therapeutic strategies for children with short stature.
- Optimizing growth hormone therapy is crucial for improving outcomes in children with growth deficiencies.
Abstract:
Short stature remains the most common reason for referral to a pediatric Endocrinologist and its management remains a challenge. One of the main controversies is the diagnosis of idiopathic short stature and the role of new technologies for genetic investigation of children with inadequate growth. Complexities in management of children with short stature includes selection of who should receive interventions such as recombinant human growth hormone, and how should this agent dose be adjusted during treatment. Should anthropometrical data be the primary determinant or should biochemical and genetic data be used to improve growth response and safety? Furthermore, what is considered a suboptimal response to growth hormone therapy and how should this be managed? Treatment of children with short stature remains a "hot" topic and more data is needed in several areas. These issues are reviewed in this paper.
Related Concept Videos
Plant Hormones
Types of Hormones
Types of Hormones
Steroids and eicosanoids fall under the category of lipid-soluble hormones. Steroids are derived from cholesterol and feature four interconnected carbon rings with variable side chains. Notable examples include estradiol from ovaries and testosterone from testes, exemplifying the critical roles of these lipid-soluble hormones in reproductive physiology. Eicosanoids, derived...
Hormonal Regulation
Hormonal Regulation
Review and Preview
Percentiles are a type of fractile that partition data into...

